7 USCAFC Decision Concerning On Sale Bar in Helsinn v. Teva
Menu
PTAB Blog
Biosimilars Blog
RF 360

In the News

Insightful. Precise. Skilled.

USA Court of Appeals for the Federal Circuit Decision Concerning on Sale Bar in Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc.

Authored by Sharon E. Crane for FICPI

August 23, 2017

Partner Sharon E. Crane authored a report, published by Fédération Internationale des Conseils en Propriété Industrielle (FICPI) on August 23, 2017, titled "USA Court of Appeals for the Federal Circuit Decision Concerning on Sale Bar in Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc." The report was also included in FICPI's August 29, 2017, newsletter.

FICPI represents an important constituency within the international IP system, as it is the only international NGO whose membership consists exclusively of IP attorneys in private practice. Dr. Crane is a member of CET Group 5 - Biotechnology and Pharmaceuticals.

Dr. Crane's full report on the decision can be found here.

You can also find the full Court of Appeals for the Federal Circuit decision here